Irene Perlich - Net Worth and Insider Trading
Irene Perlich Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Irene Perlich owns 1 companies in total, including NGM Biopharmaceuticals Inc (NGM) .
Click here to see the complete history of Irene Perlich’s form 4 insider trades.
Insider Ownership Summary of Irene Perlich
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NGM | NGM Biopharmaceuticals Inc | 2023-09-15 | Principal Accounting Officer |
Irene Perlich Trading Performance
Irene Perlich Ownership Network
Ownership Network List of Irene Perlich
Ownership Network Relation of Irene Perlich
Irene Perlich Owned Company Details
What does NGM Biopharmaceuticals Inc do?
Who are the key executives at NGM Biopharmaceuticals Inc?
Irene Perlich is the Principal Accounting Officer of NGM Biopharmaceuticals Inc. Other key executives at NGM Biopharmaceuticals Inc include director & 10 percent owner David V Goeddel , 10 percent owner Column Group L P , and Chief Financial Officer Jean-frederic Viret .
NGM Biopharmaceuticals Inc (NGM) Insider Trades Summary
Over the past 18 months, Irene Perlich made no insider transaction in NGM Biopharmaceuticals Inc (NGM). Other recent insider transactions involving NGM Biopharmaceuticals Inc (NGM) include a net purchase of 67,893 shares made by Column Group L P , and a net purchase of 26,811 shares made by David V Goeddel .
In summary, during the past 3 months, insiders sold 0 shares of NGM Biopharmaceuticals Inc (NGM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NGM Biopharmaceuticals Inc (NGM) were sold and 94,704 shares were bought by its insiders, resulting in a net purchase of 94,704 shares.
NGM Biopharmaceuticals Inc (NGM)'s detailed insider trading history can be found in Insider Trading Tracker table.
NGM Biopharmaceuticals Inc Insider Transactions
Irene Perlich Mailing Address
Above is the net worth, insider trading, and ownership report for Irene Perlich. You might contact Irene Perlich via mailing address: C/o Ngm Biopharmaceuticals, Inc., 333 Oyster Point Boulevard, South San Francisco Ca 94080.